Sacheerome Ltd (NSE - SME: SACHEEROME) A Niche Play on India’s Fragrance & Flavours Sector

[rk1771]

Company: Sacheerome Limited
Sector: Speciality Chemical
Exchange: NSE Emerge

Basic Details
• Market Cap: ₹700 crores
• Issue Price: ₹102
• Current Price: ₹312 (as of 03.06.2026)
• Listing Date: 16.06.2025

Financial Highlights

Sacheerome has shown strong top-line acceleration over the last five financial years. Revenue grew from ₹64 Crores in Mar 2022 to ₹152 Crores in Mar 2026. This represents a robust 4-year Sales CAGR of approximately 24.15%.

Operating profit surged more than 4x from ₹9 Crores (Mar 2022) to ₹37 Crores (Mar 2026). Operating Profit Margin (OPM) improved steadily every single year, moving from 13% in Mar 2022 to 24% in Mar 2026. This indicates increasing pricing power, a higher mix of premium products, or superior manufacturing efficiencies as they scaled.

ROCE has remained consistently above 20%- it was 39% in FY 2025 and 36% in FY 2026 on expanded equity. It is essentially a debt free company.
Cash flow from operating activity has remained positive, on many years CFO has remained higher that operating profit.

Business Overview

Incorporated in 1992 by Mr. Manoj Arora, Sacheerome is a specialized B2B player in the Fragrance and Flavours (F&F) industry. The F&F segment is known for being highly “sticky” — fragrances and flavours form a tiny fraction of an FMCG product’s raw material cost, yet they are disproportionately responsible for brand recall, customer preference, and product identity.

Fragrances (Legacy Business): Custom compounds for Personal Care, Hair Care, Home Care, Fine Fragrances, and Cosmetics.

Flavours (Ventured in 2014): Formulations for Beverages, Bakery, Confectionery, Dairy, and Health & Nutrition products.

The company has come out with investor presentation lately-

Sacheerome Investor Presentation- May 2026.pdf (4.9 MB)

Investment Thesis

Moat and Competitive Position

High Switching Costs: FMCG companies almost never change the olfactory or taste profile of a successful product. Once a company like Sacheerome wins a “brief” and is embedded in a product’s formulation, they enjoy annuity-like recurring revenues for the lifespan of that product.

R&D Heavy Engine: Out of a relatively lean total workforce (~160 employees), Sacheerome employs a dedicated R&D team of 54 specialists (including trained flavourists and perfumers).

Capacity Expansion: The company operates out of New Delhi with an installed annual production capacity of 7,60,000 Kg, providing enough headroom to scale alongside FMCG clients. The facility is working on almost 100% capacity.

Sacheerome is currently executing a major capacity expansion to scale its production capabilities and support future growth. The company is establishing a state-of-the-art manufacturing facility at Gautam Buddha Nagar, Uttar Pradesh, located near the Noida International Airport. Built on a land area of 21,023 sq. meters, the new plant will feature a dual-tower setup—one tower dedicated entirely to fragrances and the other to flavors. The total estimated CAPEX for the project is approximately ₹184.16 crores. The funding is drawn from a combination of the company’s recent IPO proceeds and internal cash accruals.

To enhance operational efficiency, precision, and speed, the facility will incorporate automated robotic manufacturing processes, including robotic dispensers. It will also house a specialized research and innovation center, an application center, a consumer evaluation center, and a perfumery training facility. Given this revised schedule issued by the company, the YEIDA facility is likely in the final stages of completion. The new facility at YEIDA will increase the company’s production capacity by an estimated 20 lakh kg (2 million kg) per annum. This expansion will take Sacheerome’s total installed annual capacity from its current 7.6 lakh kg up to 27.6 lakh kg (4X).

-Growth is likely to come through capacity expansion and operating leverage.

Valuation
For a high-margin, debt-free SME operating in the sticky B2B flavours and fragrances market, a P/E of ~25x–26x presents a classic “Growth at a Reasonable Price” (GARP) scenario. The stock trades favorably compared to larger listed peers like S H Kelkar, and the primary catalyst to watch is the successful August 2026 commissioning of their new UP facility, which will dictate their next phase of revenue expansion.

Growth Catalysts
-Higher Capacity

-Margin expansion through operating leverage

-Deepening market penetration with export focus.

Risk:

-A major growth catalyst for Sacheerome is the establishment of its new, state-of-the-art manufacturing plant in YEIDA, Uttar Pradesh, funded by IPO proceeds. Any delays, cost overruns, or logistical issues in completing and scaling this automated facility could negatively impact projected revenue and growth targets.

-The Fragrance and Flavours (F&F) industry is highly competitive, requiring continuous innovation.

-The company’s products must adhere to stringent global guidelines, including those set by IFRA, the European Commission (EU), FSSAI, FEMA, and ISO 9001:2015. Failure to comply with these evolving global standards could result in lost business or regulatory penalties.

-Investing in microcaps is inherently risky and my result in 100% capital loss.

Disclosures:
Invested and biased. No relationship with company or promoters.

Disclaimer
SME stocks carry higher risks due to their smaller size, limited operating history, and relaxed regulatory requirements. This analysis is for educational purposes only and should not be considered as investment advice. Always conduct your own research or consult with sebi registered financial advisors before making investment decisions.

[Prabhat_Mohanty]

Thank you for this new thread on a new company in fragrance sector. I was quite surprised to find their numbers which look very good compared to S H Kelkar. Though SHK is the largest in the sector and much bigger, they are struggling for quite sometime in terms of bottomline. In fact, management has warned that next few qtrs may be worse due to rise in raw material cost.

[Abhishek_Menon]

Thanks for this thread. What percentage of sales are they planning to export in the near future?

I believe Sanshi Fund - which is Mukul Agarwal’s CAT III AIF has also invested in this company. Looks interesting !

[rk1771]

S H Kelkar is a different business than Sacheerome. While S H Kelkar does direct B2B work with large FMCG players, a massive chunk of their revenue comes from a deeply entrenched distributor network catering to the unorganized and small-scale MSME market in India. Thus their products are more commodity like.

Sacheerome operates almost entirely on a “Brief-to-Formulation” model directly with corporate FMCG and D2C brands. S H Kelkar has massive scale, but its distributor-led exposure dilutes its gross margins during raw material volatility. Sacheerome, by acting as a specialized, direct R&D partner to brands, avoids the commodity trap. This direct integration is precisely why they can sustain a higher margin.

The management explained it in latest investor meet-

“You see, ours is a R&D-driven business, innovation-driven business. We have the very, very strong innovation teams and we are at the same time improvising on the – our innovation side. Right now, we are spending around 2.3% on our R&D of the total sales.

Question: And do we do R&D for our customers as well, Sir?

Ans: You know, in fact, we do for our customers only. We get the brief from our customers to, you know, provide the fragrance or the flavor as per their requirement of the demography, geography, gender, age group, income group, you know, as per the trends. We also give the trends. And yes, ours is a business which is driven by the R&D and that is the USP of Sacheerome.”

The management has given decent growth target- 200 crores topline with 25% Ebidta in 2026-27. The new facility is likely to start in August this year. This is the transacript of the investor meet- happy reading,

SACHEEROME_04062026121927_H2_FY_26_Earning_Call_Transcript_Intimation.pdf (326.9 KB)

[anjanikari]

This company came to my radar last week. Thanks for starting the thread. While Overall numbers and promoters experience seems good after going through the last 2 transcripts, I am not able to comprehend few things:

1. Company is doing new capes which will increase the existing capacity by 4x. However promoters guidance is revenue is only 200 cr and 250 cr for FY27 and FY28. I understand promoters want to be conservative, but even if we consider 50% utilisation (new plant) in FY28 still revenue would be around 370 cr, while promoters guided for 250cr. This seems to be ultra conservative

If I take take promoters guidance of 250 cr , then ebitda would be 62 cr, and considering the interest of around 4-5 cr and depreciation of around 10 cr, overall PBT would be 47 cr in FY28 which is just 12-13 growth on annual basis

2. In the last 2 years Ebitda margins have increased by 6% , while management stated that this is due to increase in operating efficiencies, one of the major driver was decrease in employee expense by 4%. I am not sure how much sustainable is this?

If promoters are ultra conservative and are actually able to maintain the existing asset turnover ratio with profitability, then this company can give good returns

Disc: Not invested

[rk1771]

Sacheerome is not a commodity player, and hence ramp up capacity will not increase the topline like commodity steel or cement player. The company work on brief to product model. Sacheerome’s R&D team works to win these specific briefs. Once won, the formulation is locked into the client’s product line, creating annuity-like recurring revenue. Winning and migrating these high-volume briefs takes time.

Yes, ramp up capacity does give a headroom to grow.

The company has increased it’s topline from 70 crores to 152 crores in last 3 year, a CAGR close to 25 percent. As management guided, this looks like achievable. If it grows by say 30 or 35 percent sometime, it is a bonus.

Thus year margins may be a bit subdued due to higher depreciation charges, may be some interest cost and higher manufacturing and administrative cost of bigger setup, it shall be commendable if they continue with FY 2026 margins, which the management is guiding.

[sameernics]

Just wondering… with West Asia war, isn’t entire FMCG consumption exposed as the oil prices elevated for a prolonged period of time? The full impact of inflation I guess will play out over the course of the year and that is when one will start to see big cutbacks on consumption and hence the demand would slow down for Sacheerome and a possible impact to their expansion plans too ?